Biotech stocks are coming back into favour within the pharmaceuticals sector, and it is the largest ...
Biotech stocks are coming back into favour within the pharmaceuticals sector, and it is the largest stocks that offer the higher security. Pharmaceuticals rely on a consistent output of new and lucrative products to replace those that lose their patent and become far less profitable. Antony Milford, manager of the Framlington health fund, thinks that, with some exceptions, there have been few such failures to come up with new products. But he believes pharmaceuticals will have a much harder time in the next five years and biotechs are well positioned to supplement the supply lines of the...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes